Literature DB >> 6315905

Transfusion-associated cytomegalovirus infection and acquired immune deficiency syndrome in an infant.

K Shannon, E Ball, R L Wasserman, F K Murphy, J Luby, G R Buchanan.   

Abstract

An infant who received multiple blood transfusions in the neonatal intensive care unit developed a transfusion-associated CMV infection at age 11 weeks and thereafter was noted to have hepatosplenomegaly, mitogen hyporesponsiveness, persistent viruria, an abnormal distribution of T-lymphocyte subpopulations, and poor growth. He has had recurrent opportunistic infections, including Pneumocystis carinii pneumonia. Six donors of blood products received by this infant were investigated; one was found to have chronic lymphadenopathy, weight loss, intermittent diarrhea, lymphopenia, and a profound depression of lymphocytes with a helper/inducer surface phenotype (T4 positive). Family members have an abnormal distribution of T cell subpopulations similar to those reported in asymptomatic homosexuals. The course of disease in our patient suggests that acquired immune deficiency syndrome may be transmitted to young infants via blood products.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6315905     DOI: 10.1016/s0022-3476(83)80701-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  3 in total

1.  Immunological changes in beta-thalassemia major patients positive for HTLV-III antibodies.

Authors:  M A Romeo; G Russo Mancuso; L Mauro; A Sciotto; M A Romeo; F Di Gregorio; G Giammanco; G Schiliro
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

2.  Human immunodeficiency virus infection in multi-transfused patients with thalassaemia major.

Authors:  P E Manconi; C Dessí; G Sanna; F Argiolu; P Pellegrini-Bettoli; R Piro; O Masotti; A Cao
Journal:  Eur J Pediatr       Date:  1988-04       Impact factor: 3.183

Review 3.  Perinatal viral infections.

Authors:  C G Prober; A M Arvin
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.